Table 2: The direct unit cost of health services granted from the budget (PLN) in a particular form of sarcoidosis, including the type of benefit and the number of comorbidities. (PLN to EUR according to the NBP exchange rate from 2019-02-08: EUR/PLN=0.2321).

Type of Disease The Average Direct Unit Cost of Treatment in the Study Period
2011-2015 [PLN / EUR]
Type of Treatment Number of Comorbidities with Sarcoidosis
Sarcoidosis D86
as the underlying diagnosis		 O H 0 1 2 3
Total 70.72
16.41 		5 115.17
1 187.23 		2 271.29
527.35 		4 045.42
939.27 		4 600.40
1 068.12 		4 988.80
1 158.30
Unspecified sarcoidosis 69.94
16.23		 4 665.93
1 082.96		 2 460.68
571.32		 3 039.05
705.61		 3 661.88
850.22		 4 525.50
1 050.73
Sarcoidosis of other
and combined sites		 52.03
12.08		 4 996.67
1 159.73		 2 265.91
526.10		 4 188.68
972.53		 4 698.08
1 090.80		 8 060.00
1 871.37
Sarcoidosis of lung 72.89
16.92		 5 235.45
1 215.15		 2 117.67
491.68		 4 307.53
1 000.12		 4 793.10
1 112.86		 4 938.36
1 146.59
Sarcoidosis of skin 36.73
8.53		 1 846.95
428.68		 715.12
166.04		 1 015.93
235.88		 1 716.00
398.42		 1 716.00
398.42
Sarcoidosis of lymph nodes 69.83
16.21		 5 276.25
1 224.62		 2 912.93
676.32		 4 159.71
965.80		 4 807.15
1 116.12		 5 640.29
1 309.56
Sarcoidosis D86
as a comorbid diagnosis		 O H 0 1 2 3
Total 69.52
16.14 		3 154.86
732.49 		- 2 137.99
496.40 		2 515.90
584.14 		3 267.64
758.68

O – Outpatient visit
H – Hospitalization, stationary treatment.